Sharing Life Sciences Innovations
Acquisitions of Biotech companies: a good or a bad thing?
When on the 8th January 2018 the news travelled that Novo Nordisk made a €2.6bn bid for Belgium’s Ablynx, only to be leapfrogged a few weeks later by the € 3.9bn Sanofi bid, we immediately picture…
DNA as a storage device for big data
Sometimes science fiction seems to become real right in front of our eyes. Slowly but surely, our genes are revealing all their secrets to us. We are currently able to read our genetic code faster…
Curing hay fever - ASIT Biotech allergy vaccines
The sun is shining, the grass is green, but hay fever season is at its peak! Many people (myself included) will spend a lot of money on antihistamines and tissues this summer. Wouldn’t it be lovel…
TrinCE transfection wins pitch awards
The pitching session at Knowledge for Growth 2018 gave a select number of start-ups a chance to present their company to a top panel of potential investors. The winner of this year’s pitch awards …
CD3 as co-creator of drugs with academia and pharma
The Center for Drug Design and Discovery (CD3), based in Leuven, bridges the gap between innovative biomedical research emerging from academic institutions or SMEs and pharmaceutical companies. Th…
Visualizing the deep with a drivable endoscope that crawls into the sinus anatomy!
Do you suffer from chronic sinusitis? 3NT Medical have developed a highly advanced endoscope that allows access, visualization and treatment of the remote sinuses, in a minimally invasive manner. …
How to build a “European Amgen”
There are still very few large European biotech companies to compete with the Amgens and Gileads of the world. Only a handful of European biotech companies have managed to stay independent, grow,…
Big data, big produce – Trends in agri-biotech
In the last few decades, with the introduction of GMOs, the agricultural industry was turned upside down. Major consolidations between companies took place, while sustainability and big data have …
Is innovation killing the pharmaceutical industry?
In the past few years, the speed at which new drugs have been coming to the market has accelerated significantly [1]. This means there is a lot more competition than before, greatly affecting the …
Confo Therapeutics is awarded a EUR 1M grant to increase its screening capabilities
Confo Therapeutics announced today that it has received a €1 million grant from the Flemish Government through Flanders Innovation & Entrepreneurship (VLAIO). The grant will be used to support the…
Sanofi acquires Ablynx for €3.9 billion
Sanofi and Ablynx entered into a definitive agreement under which Sanofi will offer to acquire all of the outstanding ordinary shares, including shares represented by American Depositary Shares (A…
Nominations open for Dr. Paul Janssen Award
Have you ever heard from the Dr. Paul Janssen award? It's an acknowledgement for biomedical research almost as important as a Nobel Prize. A trophy sculpture, along with $200,000 cash, will go to …
Join our 20.000 subscribers and receive the monthly newsletter for free!
Upcoming events
CTLS2018@VIB
Ghent, Belgium
Sun 01 Jul 2018 - Wed 04 Jul 2018
01 Jul 09:00
- 04 Jul 17:00
Core Technologies For Life Sciences After two successful editions of the CTLS conference (at Institut Pasteur, Paris in 2014 and at EMBL, Heidelberg in 2016), VIB is honoured to organize …
Dr. Paul Janssen Award for Biomedical Research
Janssen Pharmaceutica, Turnhoutseweg 30, 2340 Beerse
Thu 06 Sep 2018
16:30
Johnson & Johnson has named James Allison, Ph.D., of University of Texas MD Anderson Cancer Center, winner of the 2018 Dr. Paul Janssen Award for Biomedical Research. Dr. Allison won for pioneerin…
Structural Dynamics in Cellular Communication (2nd edition)
Brussels, Belgium
Thu 20 Sep 2018 - Fri 21 Sep 2018
20 Sep 09:00
- 21 Sep 17:00
After a successful first edition in January 2015, with a great audience and speakers such as Nobel Prize winner Ada Yonath, we are honored to announce a second edition. This conference wi…
